Fat Induced Insulin Resistance and Atherosclerosis

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2014

Study Completion Date

June 30, 2015

Conditions
Other Fatty Acid Oxidation DisordersDiabetes MellitusInsulin Resistance
Interventions
OTHER

Lipid/heparin

"32 healthy volunteers will undergo euglycemic - hyperinsulinemic clamping without radioactive isotopes and with (n=16) and without (n=16) lipid/heparin co-infusion for 8 hours.~Serial (at 0, 1, 2 and 4 h) muscle and fat biopsies and serial blood samples (q' 1 h) will be obtained. The following measurements will be obtained in muscle biopsies and T-cell extracts: PKC-βI and II and PKC-δ, IKK, IκB-α, NFκB, IRS-1 tyrosine phosphorylation, IRS-1 associated PI3- kinase, ICAM, VCAM and e-selectin mRNAs."

Trial Locations (1)

19140

Temple University Hospital, Philadelphia

All Listed Sponsors
lead

Temple University

OTHER

NCT02348190 - Fat Induced Insulin Resistance and Atherosclerosis | Biotech Hunter | Biotech Hunter